2. Gene
  3. PCSK9 - proprotein convertase subtilisin/kexin type 9 Gene

PCSK9 - proprotein convertase subtilisin/kexin type 9 Gene

  • 基因
  • 蛋白
  • 相关产品
  • 直系同源

种属: Macaca fascicularis

基因 ID: 102142788 | 基因类型: protein coding

关于 PCSK9

PCSK9 基因产物(5)

mRNA Protein Name
XM_005543260.3 XP_005543317.2 proprotein convertase subtilisin/kexin type 9 isoform X2
XM_005543259.3 XP_005543316.2 proprotein convertase subtilisin/kexin type 9 isoform X1
XM_005543258.3 XP_005543315.2 proprotein convertase subtilisin/kexin type 9 isoform X1
XM_045370394.1 XP_045226329.1 proprotein convertase subtilisin/kexin type 9 isoform X1
XM_005543257.3 XP_005543314.2 proprotein convertase subtilisin/kexin type 9 isoform X1
蛋白主名 其他名称

proprotein convertase subtilisin/kexin type 9

相关产品

Approval
生物活性分子 (2)
目录号 产品名 作用方式
纯度 是否罕见病
HY-132591A Inclisiran sodium Inhibitor 98.91% 否
HY-132591 Inclisiran Inhibitor 99.80% 否
抗体抑制剂 (1)
目录号 产品名 作用方式
纯度 是否罕见病
HY-P9928 Alirocumab Inhibitor 97.00% 否
Clinical Phase
生物活性分子 (5)
目录号 产品名 作用方式
纯度 Phase
HY-12090 Anacetrapib Inhibitor 99.25% Phase 3
HY-148673 AZD0780 Inhibitor 99.93% Phase 2
HY-158825 Cepadacursen sodium / Phase 2
HY-112598A PF-06815345 hydrochloride Inhibitor 98.15% Phase 1
HY-112598 PF-06815345 Inhibitor / Phase 1
抗体抑制剂 (7)
目录号 产品名 作用方式
纯度 Phase
HY-P9928A Alirocumab (anti-PCSK9) Inhibitor 98.24% Phase 4
HY-P99822 Recaticimab Inhibitor 99.71% Phase 4
HY-P99552 Tafolecimab Inhibitor 95.04% Phase 4
HY-P99187 Bococizumab Inhibitor 99.80% Phase 3
HY-P99773 Ongericimab Inhibitor / Phase 3
HY-P99696 Lerodalcibep / Phase 3
HY-P99626 Frovocimab Inhibitor 96.78% Phase 2
Pre-clinical Phase
生物活性分子 (62)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-120088A PF-06446846 hydrochloride Inhibitor 99.44% 否
HY-12402 SBC-115076 Inhibitor 99.28% 否
HY-P4153 Enlicitide chloride Inhibitor 99.63% 否
HY-P2276 Pep2-8 Inhibitor 99.74% 否
HY-152221 PCSK9-IN-10 Inhibitor 98.89% 否
HY-143221 AS-Inclisiran sodium Inhibitor 96.58% 否
HY-W510159 5-O-Methylembelin Inhibitor 98.84% 否
HY-143219 SS-Inclisiran sodium Inhibitor 97.91% 否
HY-152223 PCSK9-IN-11 Inhibitor 99.30% 否
HY-101354 R-IMPP Inhibitor 98.76% 否
HY-150223 GalNAc unconjugated/naked Inclisiran Inhibitor 92.95% 否
HY-148687A SPC5001 sodium Inhibitor 98.89% 否
HY-101832 SBC-110736 Inhibitor 99.55% 否
HY-130245 PCSK9 degrader 1 Degrader 98.33% 否
HY-143220 SS(no Galnac)-Inclisiran sodium Inhibitor 98.05% 否
HY-157434 PCSK9-IN-23 Inhibitor 99.57% 否
HY-148758 PCSK9-IN-13 Inhibitor 98.00% 否
HY-141714 SBC-115337 Inhibitor 98.02% 否
HY-148687 SPC5001 Inhibitor 93.97% 否
HY-P2276A Pep2-8 TFA Inhibitor 99.44% 否
HY-161940 PCSK9-IN-30 Inhibitor / 否
HY-163794 DC371739 Inhibitor 95.56% 否
HY-147252A Bezeparsen sodium Inhibitor / 否
HY-161939 7030B-C5 Inhibitor 99.78% 否
HY-162562 E28362 Inhibitor ≥90.0% 否
HY-120088 PF-06446846 Inhibitor / 否
HY-139998 PCSK9-IN-3 Inhibitor / 否
HY-148626 CVI-LM001 Inhibitor / 否
HY-134482 PCSK9-IN-1 Inhibitor / 否
HY-148689 SPC4061 Inhibitor / 否
HY-148689A SPC4061 sodium Inhibitor / 否
HY-153451 PCSK9-IN-15 Inhibitor / 否
HY-130245A (R,R)-PCSK9 degrader 1 Degrader / 否
HY-RS10177 PCSK9 Human Pre-designed siRNA Set A Inhibitor / 否
HY-141724 PCSK9 ligand 1 Inhibitor / 否
HY-161435 PCSK9-IN-27 Inhibitor / 否
HY-161941 MeIm Inhibitor / 否
HY-153454 PCSK9-IN-18 Inhibitor / 否
HY-153452 PCSK9-IN-16 Inhibitor / 否
HY-176043 PCSK9 autophagic degrader 2 Degrader / 否
HY-161942 PCSK9-IN-31 Inhibitor / 否
HY-153453 PCSK9-IN-17 Inhibitor / 否
HY-160036 PCSK9-IN-22 Inhibitor / 否
HY-147252 Bezeparsen Inhibitor / 否
HY-146084 PCSK9 modulator-3 Modulator / 否
HY-153391 PCSK9-IN-14 Inhibitor / 否
HY-128334 PCSK9 modulator-2 Modulator / 否
HY-N10702 PCSK9-IN-9 Inhibitor / 否
HY-146085 PCSK9 modulator-4 Modulator / 否
HY-163141 PCSK9-IN-24 Inhibitor / 否
HY-P11071 PCSK9 Inhibitor, EGF-A Inhibitor / 否
HY-161434 PCSK9-IN-26 Inhibitor / 否
HY-155006 PCSK9-IN-19 Inhibitor / 否
HY-132897 PCSK9-IN-2 Inhibitor / 否
HY-164344 PCSK9 allosteric binder-1 / 否
HY-175189 PCSK9-IN-33 Inhibitor / 否
HY-158827A AZD8233 sodium / 否
HY-168156 PCSK9-IN-32 Inhibitor / 否
HY-161938 BRD8518 Inhibitor / 否
HY-158827 AZD8233 / 否
HY-159595 PCSK9-IN-29 Inhibitor 99.44% 否
HY-155415 PCSK9-IN-20 Inhibitor / 否
抗体抑制剂 (7)
Cat. No. 产品名 作用方式
纯度 是否罕见病
HY-P99871 Ebronucimab Inhibitor / 否
HY-P99251 Lodelcizumab Inhibitor ≥99.0% 否
HY-P99251 Lodelcizumab Inhibitor ≥99.0% 否
HY-P99816 Ralpancizumab Inhibitor / 否
HY-P990485 Anti-PCSK9 Antibody Inhibitor 98.39% 否
HY-P991721 Ticalicibart Inhibitor / 否
HY-P991343 ALD306 Inhibitor / 否

直系同源

种属 基因名 来源 基因 ID
Homo sapiens PCSK9 NCBI NCBI:255738
Mus musculus PCSK9 NCBI NCBI:100102
Rattus norvegicus PCSK9 NCBI NCBI:298296
Macaca mulatta PCSK9 NCBI NCBI:717147
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z